GlassScriptPhysician profile
Diana P Blum
NPI 1952599839
$13,082.99
in general payments reported to CMS, 2019-2025
20 companies · $427 in 2025
The $427 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,978 · 2020: $5,573 · 2021: $744 · 2022: $79.68 · 2023: $53.04 · 2024: $228 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $5,399.71 | 2019-2025 | Rytary, Ongentys |
| Lundbeck LLC | $4,466.61 | 2019 | |
| Kyowa Kirin, INC. | $1,715.22 | 2019-2024 | Nourianz |
| Mdd US Operations, LLC | $361.47 | 2019-2025 | Gocovri, Apokyn |
| Ucb, INC. | $241.15 | 2019 | |
| Abbvie INC. | $238.07 | 2022-2025 | Duopa |
| Adamas Pharmaceuticals, INC. | $96.78 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $82.03 | 2019-2020 | |
| Amgen INC. | $67.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.09 | 2019 | |
| Sunovion Pharmaceuticals INC. | $53.33 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $49.40 | 2019 | |
| Acorda Therapeutics, INC | $46.51 | 2019-2020 | |
| Bausch Health US, LLC | $44.47 | 2019 | |
| Lilly USA, LLC | $41.19 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $30.45 | 2019 | |
| Avion Pharmaceuticals | $24.95 | 2022 | |
| Endo Pharmaceuticals INC. | $23.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.34 | 2019 | |
| Allergan, INC. | $18.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.